Formulation

Dec 02, 2018
Pharmaceutical Technology
Antibody-based drugs offer new mechanisms of action and greater specificity.
Nov 21, 2018
Sponsored Content
The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides development opportunities for many companies, but also provides significant challenges.
Nov 08, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.
Nov 02, 2018
Pharmaceutical Technology
As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.
Nov 01, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The acquisition expands the company’s formulation and analytical R&D services.
Oct 15, 2018
By Pharmaceutical Technology Editors
The company’s planned investment in its alkoxylation facility in the United States Gulf Coast will also expand production capacity for its polyethylene glycols.
Oct 03, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Lonza’s Capsugel Colorista capsule R&D solution can cut overall development time and offers greater flexibility during technical color development.
Oct 02, 2018
Pharmaceutical Technology
Lipid-based formulations offer a means of addressing the physicochemical and biological challenges of poorly soluble APIs.
Sep 20, 2018
By Pharmaceutical Technology Editors
The company will showcase its gelatins for advanced pharmaceutical and biomedical applications at CPhI Worldwide on Oct. 9–11, 2018 in Madrid, Spain.
Sep 20, 2018
By Pharmaceutical Technology Editors
Omya will showcase Omyapharm 500-OG (calcium carbonate and tribasic calcium phosphate) at CPhI Worldwide in Madrid, Spain, on Oct. 9–11, 2018.
native1_300x100
lorem ipsum